The high concentration in brain of unbound L-glutamic acid tin its anionic
form, L-glutamate) fuelled considerable speculation as to its role in centr
al nervous function more than 50 years ago. Claims in the 1940s that it cou
ld improve cognitive acuity in patients with mental impairment were particu
larly intriguing, though later refuted. In the early 1950s Hayashi [(1954)
Keio J. Med. 3, 183-192] found that L-glutamate could cause convulsions and
proposed that it might be a central synaptic transmitter. Soon thereafter,
Curtis and colleagues [Curtis, Phillis and Watkins (1959) Nature (London)
183, 611] showed that L-glutamate depolarized and excited central neurons,
as expected for an excitatory transmitter; however, various aspects of the
action of L-glutamate seemed to argue strongly against a transmitter functi
on. This negative view prevailed for some 20 years, before compelling evide
nce for such a role was adduced. Over the last two decades, extensive resea
rch has revealed a host of glutamate receptor subtypes, subserving several
different functions in excitatory synaptic transmission. This paper gives a
very brief and personal overview of the development of the field over the
last 50 years from a mainly pharmacological standpoint.